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Replicating amyloids, called prions, are responsible for trans-
missible neurodegenerative diseases inmammals and someher-
itable phenotypes in fungi. The transmission of prions between
species is usually inhibited, being highly sensitive to small dif-
ferences in amino acid sequence of the prion-forming proteins.
To understand the molecular basis of this prion interspecies
barrier, we studied the transmission of the [PSI] prion state
from Sup35 of Saccharomyces cerevisiae to hybrid Sup35 pro-
teins with prion-forming domains from four other closely
related Saccharomyces species. Whereas all the hybrid Sup35
proteins could adopt a prion form in S. cerevisiae, they could not
readily acquire the prion form from the [PSI] prion of S. cerevi-
siae. Expression of the hybrid Sup35 proteins in S. cerevisiae
[PSI] cells often resulted in frequent loss of the native [PSI]
prion. Furthermore, all hybrid Sup35 proteins showed different
patterns of interaction with the native [PSI] prion in terms of
co-polymerization, acquisition of the prion state, and induced
prion loss, all of which were also dependent on the [PSI] vari-
ant. The observed loss of S. cerevisiae [PSI] can be related to
inhibition of prion polymerization of S. cerevisiae Sup35 and
formation of a non-heritable form of amyloid. We have there-
fore identified two distinct molecular origins of prion transmis-
sion barriers between closely sequence-related prion proteins:
first, the inability of heterologous proteins to co-aggregate with
host prion polymers, and second, acquisition by these proteins
of a non-heritable amyloid fold.
Noncovalent polymerization of proteins coupled with their
deep conformational rearrangement can result in the forma-
tion of amyloid fibers possessing a regular cross--sheet struc-
ture. Amyloid formation is associated with 30 different dis-
eases in humans and other mammals, many of which are
neurodegenerative in nature, e.g. Alzheimer, Parkinson, and
Huntington diseases (1). Amyloid diseases are noninfectious,
except for the prion diseases that are linked to the PrP protein
and that include Creutzfeldt-Jakob disease, sheep scrapie, and
other transmissible spongiform encephalopathies (2–5).
Importantly, prion transmission between animal species is
often impeded or blocked, even when the difference in
sequence of the PrP proteins is small (6). For example, ovine
prions cannot directly infect humans, but they can infect cattle,
and bovine prions can then infect humans, although ineffi-
ciently (7, 8).
Prions have also been described in yeast; these prions are
generally not detrimental and manifest themselves as genetic
elements with unusual inheritance properties (9–15). Among
yeast prions, the best studied is [PSI], the prion determinant
that gives rise to a nonsense suppressor phenotype as a conse-
quence of the aggregation and partial inactivation of the trans-
lation termination factor Sup35 (eRF3) (16–18). The N-termi-
nal domain of Sup35 is essential for the de novo appearance and
maintenance of [PSI] and is therefore referred to as the prion-
forming domain. The function of the chargedmiddle domain of
Sup35 is unclear, whereas the C-terminal domain performs the
essential translation termination activity of this protein (19, 20).
In [PSI] cells, Sup35 polymerizes via its prion domain (21).
Similar to mammalian prions, [PSI] can exist in multiple vari-
ants or strains, which can be distinguished by the strength of
their nonsense suppressor phenotype and stability of inherit-
ance. Strong [PSI] variants show efficient nonsense suppres-
sion and high mitotic stability, whereas weak variants show
inefficient nonsense suppression and low mitotic stability (22,
23). The dissimilarity in the properties of the [PSI] variants
reflects heritable differences in the structure of the underlying
Sup35 prion polymers (24, 25).
The yeast [PSI] prion has been used to demonstrate conser-
vation of the prion properties of Sup35 proteins from different
distantly related yeast species and the inability to transmit the
infectious prion state between Sup35 proteins from these spe-
cies. The observed prion species barrier appears to be linked to
the inability of Sup35 molecules from different species to co-
aggregate, a prerequisite for efficient transmission of the prion
state (26–28). However, such a barrier for prion transmission
can also exist between two sequence-related prion proteins that
are able to co-aggregate or interact in polymerization. For
example, when expressed in murine cell culture, hamster PrP
blocked prion propagation of murine PrP, i.e. interacted with it
but did not acquire the prion state (29). In yeast, polymerization
of overproduced Sup35 can be seeded efficiently by an imper-
fect template, the prion form of Rnq1, but the resulting amyloid
polymers of Sup35 are predominantly non-heritable due to
their poor fragmentation by the molecular chaperone Hsp104
(30). The highly preferential formation of non-heritable poly-
mers on a prion template made up of a different protein is a
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more general phenomenon and has been reported for other
combinations of seeding and seeded proteins (31). This finding
led us to propose that the formation of non-heritable polymers
in place of heritable prion polymers may be the cause of trans-
mission barriers between prion proteins able to interact (32).
Consistent with this hypothesis, Chen et al. (33) observed
that Sup35 proteins from Saccharomyces paradoxus and Sac-
charomyces bayanus co-aggregated very efficiently with the
prion form of Saccharomyces cerevisiae Sup35 without acquir-
ing the prion state. This implied that these heterologous Sup35
proteins efficiently adopted a non-heritable amyloid structure.
However, a further study of these proteins by Chen et al. (34)
showed higher [PSI] transmission and lower Sup35 co-aggre-
gation than originally reported. Hence, the possibility of co-ag-
gregation without prion transmission cannot be reliably con-
cluded from these studies.
To check our hypothesis of the formation of non-heritable
amyloid folds, we analyzed the co-polymerization of four
closely related Sup35 proteins with the [PSI] form of S. cerevi-
siae Sup35 and established whether the [PSI] prion could be
efficiently transmitted to the heterologous proteins. In several
cases, we observed efficient co-polymerization without con-
comitant prion transmission, confirming our hypothesis. In
addition, our study shows that heterologous Sup35 proteins can
have a dominant-negative effect on [PSI] prion propagation.
These new data allow us to make the first detailed reconstruc-
tion of the molecular events responsible for [PSI] elimination
when two closely related prion proteins are expressed in the
same cell, and they point to the formation of a non-heritable
fold by heterologous Sup35 as being critical for prion transmis-
sion barriers.
EXPERIMENTAL PROCEDURES
Media, Strains, Plasmids, and Genetic Methods—Yeast cells
were grown at 30 °C on either complete (yeast extract/peptone/
dextrose (YPD)) or synthetic complete medium containing 2%
glucose. For assaying the [PSI] suppressor phenotype, selec-
tivemedia with a decreased concentration (0.07mg/ml) of ade-
nine sulfate or modified YPD (YPDred: 0.5% yeast extract, 2%
peptone, and 4% glucose) were used because these media pro-
mote accumulation of red pigment in the ade2 mutants. To
eliminate the [PSI] determinant, the cells were grown from
single cells to colonies on medium containing 3 mM guanidine
hydrochloride. DNA transformation of the yeast cells was per-
formed using the lithium acetate method (35).
Centromeric and multicopy plasmids carrying the hybrid
SUP35 genes were constructed on the basis of the pRS315-
SUP35-SE plasmid. To create this plasmid, the S. cerevisiae
genomic XhoI-XbaI fragment encompassing the SUP35 gene
was inserted into the same sites of the pRS315 polylinker. Then,
the region encoding the prion domain (amino acid residues
1–120) was replaced with a short fragment containing sites for
SmaI, BglII, SacI (Ecl136II), andNarI. The region encoding res-
idues 1–120 was amplified from the genomic DNA of the yeast
S. cerevisiae, Saccharomyces mikatae, Saccharomyces kudria-
vzevii, S. paradoxus, and S. bayanus and inserted into the BglII
and Ecl136II sites. In the constructs obtained, the coding
regions were joined seamlessly, but Met-124 was replaced with
alanine to exclude translation initiation at this residue. The
5-noncoding region was slightly altered: the region of nucleo-
tides11 to3 was replaced with sequence GATCCCCGGG-
AGATCT. The 3-HA versions of these SUP35 constructs
encoded proteins with the 3-HA tag (amino acid sequence GL-
INIFYPYDVPDYAGYPYDVPDYAGSYPYDVPDYAAQIP)
inserted after amino acid residue 251.
The S. cerevisiae strain 22V-H63-S35 (MATa ade2-1 SUQ5
kar1 lys1 his3 ura3 leu2 cyhRSUP35) and its [PSI] derivatives
were used (36). This strain carries the chromosomal deletion of
SUP35 and the pRS316-SUP35URA3 plasmidwith S. cerevisiae
SUP35. To check the ability of the hybrid proteins to acquire a
prion state, we replaced the pRS316-SUP35 plasmid with the
pRS315 LEU2 plasmids bearing the hybrid SUP35 genes. The
[psi] colonies of strain 22V-H63-S35 are distinguished by
their red color and adenine requirement because the weak ser-
ine-inserting tRNA suppressor SUQ5 (SUP16) cannot suppress
the ade2-1 ochre mutation in the absence of the [PSI] deter-
minant. This allowed selection of [PSI] in the transformants of
this strain by the appearance of the colonies with white or pink
color, depending on the [PSI] variant. To quantify the mitotic
stability of [PSI] based on the hybrid Sup35 proteins, three
colonies of each [PSI] isolate were suspended in water and
plated onto YPDred medium. Plates were incubated for 3 days,
and the percentage of red colonies was determined.
[PSI] Transmission and Curing—The efficiency of [PSI]
transmission to the hybrid Sup35 proteins was determined as
follows. 48 transformants for each combination of SUP35 type
and [PSI] variant were grown on synthetic complete medium
lacking leucine but containing uracil to allow the cells to lose
spontaneously the original URA3 SUP35-cer plasmid pRS316-
SUP35. The efficiency of transmissionwas then counted among
the Ura clones as the proportion of the Ade clones. To
ensure that the Ade clones did not contain any phenotypically
silent “ultra-weak” hybrid [PSI], the presence of Sup35 poly-
mers was checked by semidenaturing detergent-agarose gel
electrophoresis in about one-third of the Ade clones, and the
polymers were never found.
The frequency of [PSI] loss caused by the presence of hybrid
Sup35 proteins was defined as the proportion of [psi] cells in
colonies arising from single [PSI] cells and determined as fol-
lows. For each combination of hybrid Sup35 protein and [PSI]
variant, three transformants were taken, each suspended in liq-
uid synthetic complete medium and streaked to single cells on
synthetic complete medium plates containing leucine (i.e. non-
selective for plasmidswith hybrid SUP35) but lacking uracil and
low in adenine. After 4 days of growth, white or sectored colo-
nies were scored as [PSI] and red colonies as [psi]. All red
colonies were unable to grow in the absence of adenine.
Preparation of Yeast Cell Lysates—The yeast cultures were
grown in liquid medium to A600 1. The cells were harvested,
washed in water, and lysed by vortexing with glass beads in
buffer containing 30 mM Tris-HCl (pH 7.4), 150 mM NaCl, and
10 mM dithiothreitol. To prevent proteolytic degradation, 25
mM EDTA, 10 mM phenylmethylsulfonyl fluoride, and Com-
plete protease inhibitor mixture (Roche Applied Science) were
added. The cell debris was removed by centrifugation at
10,000 g for 5 min.
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Centrifugation—To separate Sup35 polymer and monomer
fractions, 100l of yeast cell lysatewas centrifuged through 100
l of a 10% sucrose cushion at 100,000  g (48,000 rpm in a
TLA-100.1 rotor, Beckman Optima TL ultracentrifuge) for 15
min at 4 °C.
Electrophoresis—Sup35 amyloid polymers were analyzed by
electrophoresis on horizontal 1.8% agarose gels with 25 mM
Tris, 250mMglycine, and 0.1% SDS (semidenaturing detergent-
agarose gel electrophoresis) (37). To analyze Sup35 polymers
and monomers in a single gel, the standard SDS-PAGE system
(38) was modified as described (39). Yeast cell lysates were
mixedwith sample buffer, incubated for 1min at room temper-
ature, and loaded onto the gel, and electrophoresis was run for
30 min. The Sup35 monomers were separated, whereas poly-
mers stopped at the start of the stacking gel. To dissolve and
analyze the polymers, sample buffer was loaded into the wells,
and the gel was sealed and boiled for 5 min. The separation was
continued after boiling. After electrophoresis, the proteins
were transferred to a Hybond ECL nitrocellulose membrane
and decorated with antibody to the Sup35N-terminal andmid-
dle domains. The bound antibodies were detected using the GE
Healthcare ECL system.
RESULTS
Design andFunctionalActivity ofHybrid Sup35Proteins—To
establish the mechanisms that prevent transmission of inher-
ited prion folds between sequence-related prion proteins, we
used Sup35 from yeast of the Saccharomyces sensu stricto
group, namely S. cerevisiae, S. paradoxus, S. mikatae, S. kudria-
vzevii, and S. bayanus (40, 41). Previous studies have shown
that the Sup35 N-terminal domain plays a key role in the “spe-
cies barrier” (26, 33). In this study, to exclude any possible influ-
ence of the middle and C-terminal domains of Sup35 on the
interactions between the heterologous Sup35 molecules, we
used hybrid SUP35 genes. These genes were created from
S. cerevisiae SUP35 by replacing the sequence encoding the
N-terminal domain (residues 1–120) with the corresponding
regions from heterologous SUP35 genes (Fig. 1). The encoded
hybrid proteins were designated as Sup35-par, Sup35-mik,
Sup35-kud, and Sup35-bay, respectively, and all constructs
were verified by DNA sequencing. The Sup35-kud sequence
has not been previously reported, and in contrast to the S. baya-
nus Sup35 sequence used by Chen et al. (33), the Sup35-bay
sequence used here did not differ from S. cerevisiae Sup35
(Sup35-cer) at position 17 (serine). The amino acid similarities
of the N-terminal regions of these proteins to the Sup35-cer
N-terminal region are 94, 89, 86, and 78%, respectively. Impor-
tantly, the prion domains of Sup35-par and Sup35-mik align
with Sup35-cer with no gaps, whereas Sup35-kud has one gap
and Sup35-bay lacks one oligopeptide repeat and has two sin-
gle-residue insertions (Fig. 1A).
To differentiate between the different Sup35 proteins, we
created an additional set of Sup35 constructs by inserting the
3-HA tag after amino acid residue 251, i.e. just before the C-ter-
minal domain (Sup35-3-HA); addition of the 3-HA tag reduced
the electrophoretic mobility of the Sup35 protein. All hybrid
Sup35 proteins, including those with the 3-HA tag, supported
viability of the otherwise Sup35-deficient 22V-H63-S35
[psi] strain. Cells producing Sup35 without a 3-HA tag
showed the expected non-suppressed phenotype, although the
red colony color was less pronounced than in the [psi] control
(Fig. 2, left panel). This phenotypic effect may be related to a
minor change in the 5-untranslated region, which led to a
FIGURE1.Sup35proteinsused.A, sequence alignmentof Sup35priondomains from S. cerevisiae (cer), S. mikatae (mik), S. kudriavzevii (kud), S. paradoxus (par),
and S. bayanus (bay). Only differing amino acid residues are shown. Gaps are shown by highlighted dashes. B, scheme of the hybrid Sup35 proteins. The Sup35
N-terminal domain (N) was replaced with analogous domains from the indicated species. In one set of constructs, the 3-HA tag was placed after residue 251.
M, middle domain; C, C-terminal domain.
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small decrease in Sup35 levels (see Fig. 4, cer lane, and supple-
mental Fig. S1). Cells producing Sup35 with the 3-HA tag
showed an Ade phenotype and white colony color, suggesting
that the 3-HA tag reduced activity of the Sup35-3-HA proteins
in translation termination.
Sup35 from Different Saccharomyces Species Can Form Pri-
ons in S. cerevisiae Cells—The concept of the prion transmis-
sion barrier implies that heterologous proteins are able to
acquire a prion state. To establish this for the hybrid Sup35
proteins, we attempted to obtain their prion state through over-
production of these proteins. The 22V-H63-S35 [psi]
[PIN] strain, carrying a centromeric LEU2-based plasmid
encoding one or other of the hybrid Sup35 proteins, was trans-
formed with a multicopy URA3-based plasmid encoding the
same hybrid Sup35, and Ade Leu clones were selected. In
most cases, the Ade phenotype was lost following growth on
the guanidine hydrochloride-containing medium, which is
indicative of the [PSI] prion being responsible for the pheno-
type. Thiswas confirmed by the presence of SDS-resistant poly-
mers of hybrid Sup35 proteins in the guanidine hydrochloride-
curable Ade clones (supplemental Fig. S2). The newly
generated hybrid [PSI] isolates varied in suppressor efficiency
and the degree of mitotic stability. The [PSI] strains based on
Sup35-mik and Sup35-bay were mainly of the weak type (sup-
plemental Table SI), the latter in agreement with previous
results (33).
Expression of Hybrid Sup35 Proteins Affects the [PSI] Phe-
notype and Propagation—To study the interaction of hybrid
Sup35 proteins with the [PSI] prion based on Sup35-cer, we
used four independent [PSI] variants of strain 22V-H63-S35:
strong (S), weak-1 (W1), weak-2 (W2), and weak-3 (W3). This
strain harbors the SUP35 chromosomal deletion and a centro-
meric URA3-based plasmid encoding Sup35-cer (36). Cells
with these [PSI] variants were transformed with centromeric
LEU2-based plasmids encoding one or other of the hybrid
Sup35 proteins or Sup35-cer as a control. The phenotypes of
resulting transformants were assessed on medium lacking Leu
and Ura to ensure coexpression of the hybrid and wild-type
Sup35 proteins in the same cell.
In contrast to wild-type Sup35 controls, all transformants
producing hybrid Sup35 without the 3-HA tag showed no
[PSI] nonsense suppression phenotype, i.e. manifested anti-
suppression (Fig. 2). This indicates that a significant proportion
of Sup35 in these cells remained soluble and functional, leading
to efficient translation termination. The antisuppressor effect
of the hybrid Sup35-3-HA proteins wasmuch less pronounced,
which suggests that the soluble Sup35 was represented mainly
by hybrid Sup35. In several cases, expression of the hybrid
Sup35 proteins caused the [PSI] loss with frequencies being
dependent on both the [PSI] variant and hybrid Sup35. For
example, weak [PSI] variants in the presence of Sup35-bay or
Sup35-mik produced [psi] cells with up to 24% frequency (the
proportion of [psi] cells in a colony), whereas expression of
Sup35-kud caused no detectable [PSI] loss (Fig. 3 and supple-
mental Table SII). The presence of the 3-HA tag did not signif-
icantly alter the measured [PSI] loss for any hybrid Sup35
(supplemental Table SII), which is consistent with the 3-HA tag
not affecting Sup35 polymerization. The ability of the hybrid
Sup35 proteins to interfere with [PSI] propagation indicates a
physical interaction between the hybrid Sup35 molecules and
the prion form of Sup35-cer.
Hybrid Sup35 Proteins Can Co-polymerize with Sup35-cer—
Toestablishwhether the hybrid Sup35 proteins are able to form
polymers in the presence of the prion form of Sup35-cer, we
used a novel electrophoretic technique that allows quantitative
analysis of the prion polymer and monomer fractions of a cell
lysate in one gel (39). This method avoids the problem encoun-
tered by the more common centrifugation-based assay, namely
that soluble Sup35 can appear in the high molecular weight
fraction through its association with ribosomes or other trans-
lation factors (18). In these experiments, we used hybrid Sup35-
3-HA proteins, which allowed us to distinguish them from
wild-type Sup35-cer by reduced electrophoretic mobility.
The hybrid Sup35 proteins showed varying degrees of
polymerization depending on which hybrid Sup35 and [PSI]
variant were used. Efficient polymerization was observed for
Sup35-par in all [PSI] variants, except forW3, and for Sup35-
mik in theW1 andW2 [PSI] variants (Fig. 4 and supplemental
Fig. S3). Centrifugation analysis of the same strains demon-
FIGURE 2. Phenotypes of the cells producing hybrid Sup35. Left panel,
[psi] cells producing only the indicated Sup35 proteins. Right panel, cells
producing Sup35-cer in the prion variant indicated at the top and hybrid
Sup35 indicated on the side. The presence of the 3-HA tag in hybrid Sup35 is
indicated at the bottom.
FIGURE 3. Frequencies of [PSI] transmission and loss. Upper, [PSI] trans-
mission to the indicatedSup35alleles. Lower, [PSI] loss in thepresenceof the
indicated Sup35 alleles. The [PSI] variants used are shown. All hybrid Sup35
proteins lacked the 3-HA tag, but the [PSI] losswas similar in the presence of
hybrid Sup35 with 3-HA (supplemental Table SII). The data in the original
digital form are presented in supplemental Tables SII and SIII.
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strated a similar extent of Sup35 polymerization (supplemental
Fig. S4).
In several cases, coexpression of the hybrid Sup35 proteins
resulted in a significant increase in soluble Sup35-cer levels
(Fig. 4). This can be explained in part by the presence of [psi]
cells in the population. However, in some cases, the proportion
of soluble Sup35-cer appeared to be higher than the observed
proportion of [psi] cells. For example, coexpression of Sup35-
mik, Sup35-bay, or Sup35-par along with Sup35-cer in the W3
[PSI] strain resulted in appearance of 10% of [psi] cells.
The levels of soluble Sup35-cer in theW3 [PSI] cells express-
ing Sup35-mik or Sup35-bay were 10–15%, and therefore,
they could be accounted for by the presence of [psi] cells.
However, the soluble fraction of Sup35-cer in the cells express-
ing Sup35-parwas higher by20%, and this value can be attrib-
uted to the inhibition of Sup35-cer polymerization by the
Sup35-par protein. Similar increased levels of soluble Sup35-
cer were caused by Sup35-mik in the W1 and W2 [PSI] vari-
ants and by Sup35-bay in the W1 [PSI] variant (Fig. 4).
In contrast to other Sup35 proteins, the Sup35-kud and
Sup35-bay proteins showed low levels of polymerization, if any
at all. However, although coexpression of Sup35-kud caused no
loss of the [PSI] prion, coexpression of Sup35-bay eliminated
weak [PSI] with 13–24% efficiency (Fig. 3), suggesting that
Sup35-bay interacted with the prion form of Sup35-cer,
whereas Sup35-kud did not.
It should be noted that the co-polymerization of hybrid
Sup35 proteins with Sup35-cer was equivalent to the levels of
their polymerized form only when [PSI] transmission was
absent or negligible. When [PSI] was transmitted with a sig-
nificant frequency, in a certain proportion of cells, hybrid
Sup35 acquired a prion fold and formed inheritable polymers
independently of Sup35-cer. The proportion of such cells
equaled the transmission efficiency and was close to zero in
most cases, excluding expression of Sup35-par in S, W1, and
W2 [PSI] cells (supplemental Table SIII). The Sup35-par co-
polymerization in S and W1 [PSI] cells could be estimated as
close to 100% and in W2 [PSI] cells as 40% (supplemental
“Methods”).
Intermolecular Transmission of the [PSI] Prion State—To
establish the frequency of the [PSI] transmission from Sup35-
cer to the hybrid Sup35 proteins, it is required to induce loss of
the URA3 plasmid encoding Sup35-cer and then score the
[PSI] phenotype. Usually, the loss of URA3 plasmids is
achieved by growing cells on 5-fluoroacetic acid-containing
medium. However, we have observed that 5-fluoroacetic acid
caused significant loss of weak [PSI] (supplemental Table
SIV), which can result in underestimation of the transmission
frequency of these [PSI] variants. This forced us to rely on the
spontaneous loss of the URA3 SUP35-cer plasmid.
No [PSI] transmission to Sup35-mik, Sup35-bay, and
Sup35-kud was detected, whereas the control transmission to
Sup35-cer occurred with 100% frequency. Sup35-par acquired
the S [PSI] variants with 68% frequency and the weak [PSI]
variants with 5–13% frequency (Fig. 3 and supplemental Table
SIII).
DISCUSSION
To define themolecular basis of interspecies prion transmis-
sion barriers, we employed the yeast [PSI] prion model.
Hybrid Sup35 proteins were created using S. cerevisiae Sup35,
but the N-terminal prion-forming domain was replaced with
the corresponding sequence from four closely related Saccha-
romyces species, S. mikatae, S. kudriavzevii, S. paradoxus, and
S. bayanus. By coexpressing these Sup35 molecules in an
S. cerevisiae strain bearing one of four [PSI] prion variants, we
have established the ability of hybrid Sup35 molecules to co-
polymerize with Sup35-cer and the efficiency with which dif-
FIGURE 4. Electrophoretic analysis of co-polymerization of hybrid Sup35
proteins.Yeast cellswith the indicated [PSI] variantswere transformedwith
centromeric plasmids producing hybrid Sup35-3-HA proteins. Cell lysates
were loaded onto gels without boiling and run for half a distance. The whole
gelswere thenboiled, and the electrophoretic separationwas continued. The
gels were blotted, and the blots were stainedwith antibody to the Sup35-cer
N-terminal and middle domains. Sx-3HA, hybrid Sup35-3-HA proteins; Sc,
Sup35-cer lacking the tag. For ease of comparison, the values for [PSI] loss
and transmission are givenbelow thegels. TheW1panel also shows lysates of
the cells having lost the plasmid encoding Sup35-cer (asterisk).
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ferent [PSI] variants can be transmitted to the hybrid Sup35
proteins. In addition, we have found that coexpression of
hybrid Sup35 proteins can destabilize native [PSI].
In the majority of cases, hybrid Sup35 proteins showed dif-
ferent patterns of physical and genetic interaction with the
[PSI] form of Sup35-cer, and this behavior also depended on
the [PSI] variant being examined. The lack of, or very weak,
interaction as assayed by all of the tests used was observed only
for Sup35-kud in all [PSI] variants and for Sup35-bay and
Sup35-mik in the S [PSI] variants.
Hybrid Sup35 Proteins Acquire a Non-heritable Fold from
Sup35-cer Prion Seeds—Two proteins were able to co-poly-
merize efficiently with the prion form of Sup35-cer: Sup35-mik
in theW1 andW2 [PSI] variants and Sup35-par in the S, W1,
andW2 [PSI] variants. However, no transmission of [PSI] to
Sup35-mikwas detected in these cases. This allowed us to char-
acterize the fold(s) acquired by Sup35-mik as non-heritable
because they could not propagate in the absence of original
prion based on Sup35-cer. Such behavior is also typical of the
non-heritable amyloids of Sup35, which cannot propagate in
the absence of the [PIN] prion (30).
The S, W1, and W2 [PSI] variants were transmitted to
Sup35-par with a frequency of 10–70% (Fig. 3 and supplemen-
tal Table SIII). Thus, in these cases, in 30–90% of cells, Sup35-
par did not acquire the prion state and efficiently co-polymer-
ized with Sup35-cer in a non-heritable fold. Despite the
significant [PSI] transmission values observed in these exper-
iments, the probability (p) with which a Sup35-par molecule
acquires the prion fold upon joining to a Sup35-cer prion poly-
mer is extremely low. In these experiments, Sup35-par binds to
Sup35-cer prion polymers very many times (n) in every cell
lineage. Because [PSI] is heritable, if the prion fold is acquired
by Sup35-par in just one such binding event in a cell, [PSI]
should be present in all progeny of this cell. Therefore, p should
be very low; otherwise, the final efficiency of the [PSI] trans-
mission (P) should approach 100%. pmay be estimated as p
P/n, when P is significantly 	100%. We estimate n as being of
the order of tens of thousands or larger, and so p is 	104.
More precise expression for p is p 1 (1P)1/n (supplemen-
tal “Methods”).
In five combinations of the Sup35 type/[PSI] variant, we
observed a significant [PSI] loss (10–24%) even though co-
polymerization of hybrid Sup35 proteins with Sup35-cer was
barely detectable. This suggests that hybrid Sup35molecules in
these cases joined the Sup35-cer polymer but as a single mole-
cule or a small number of molecules. It is likely that hybrid
Sup35 acquired an amyloid fold, but certainly this was not a
prion fold.
Previously, we have shown that prions preferentially seed
non-prion amyloids when the seeding and seeded proteins are
different (30, 31). This work shows that such a preference exists
even for closely related Sup35 proteins. These observations
suggest a certain common feature of prion folds, which makes
their formation unfavorable. This feature could relate to
another characteristic property of prions: in contrast to normal
protein folds and non-heritable amyloid folds (30), prion folds
are recognized by chaperones, such as Hsp104 and/or other
chaperones, which results in the fragmentation of prion poly-
mers. The chaperone recognition is likely to be related to the
exposure of hydrophobic amino acid residues on the surface of
amyloid (42), which is unfavorable in terms of energy because
hydrophobic residues normally tend to be buried inside of a
molecule to minimize their contact with water.
Molecular Model for the Interaction of Heterologous Sup35
with the Prion Form of Sup35-cer—All of the heterologous
Sup35 proteins studied, except for Sup35-kud in all [PSI] vari-
ants and Sup35-bay in S [PSI] variants (Fig. 5, Scenario 5),
interacted with the prion forms of Sup35-cer as judged by their
co-polymerization and induced [PSI] elimination. Elimina-
tion of native [PSI] induced by heterologous Sup35 is a novel
effect described in this work, and uncovering its mechanisms
requires a detailed analysis of howSup35-cer polymerizes in the
presence of closely related Sup35 molecules. [PSI] loss can
result from binding of heterologous Sup35 to the Sup35-cer
prion polymer end and inhibition of further Sup35-cer poly-
merization. This should bemanifested in the increased levels of
soluble Sup35-cer, and such an effect wasmost pronounced for
Sup35-mik and Sup35-bay in W1 and W2 [PSI] and for
Sup35-par inW3 [PSI] (Fig. 5, Scenarios 2 and 4). However, in
other cases, the levels of soluble Sup35-cer were not substan-
tially increased. Therefore, in these cases, joining of a hetero-
logous Sup35molecule to the end of a Sup35-cer prion polymer
did not preclude binding of Sup35-cer to the terminal hetero-
logous Sup35 and its further polymerization. However, in such
a heterotypic seeding, one should expect highly preferential
formation of a non-prion fold by Sup35-cer (Fig. 5, Scenarios 1
and 3).
Despite this, the [PSI] propagation would be expected to
continue if Hsp104 breaks the co-polymer within the original
(i.e. seeding) prion stretch of Sup35-cer (denoted by lowercase c
in Fig. 5), thus creating new polymer ends that can seed Sup35-
cer prion formation. The [PSI] prion can propagate in such a
way only if the incorporation of hybrid Sup35 into Sup35-cer
polymers occurs less frequently than the polymer fragmenta-
tionmediated byHsp104. The fragmentation frequencymay be
roughly estimated as an inverse value of the average number of
Sup35molecules in a polymer. So, S [PSI] variants with a poly-
mer size of 20 Sup35 molecules (18) would be rapidly elimi-
nated if the probability (h) of incorporation of hybrid Sup35
compared with Sup35-cer exceeds 1/20, or 5%.
FIGURE 5. Molecular scenarios for Sup35 polymerization observed in
this work. Scenarios are designated as indicated on the right. Polymers
are represented as sequences of letters corresponding to Sup35 mole-
cules and reflecting their origin: c and C denote cerevisiae, P denotes para-
doxus, M denotes mikatae, and X denotes various hybrid Sup35 proteins.
Lowercase letters designate the prion fold, and uppercase letters indicate
the non-heritable fold. For simplicity, polymer growth is shown only on
the right. The prion fold reproduction may occur only in area I after its
fragmentation by Hsp104. Gray letters in area III reflect the lack or reduced
probability of polymerization. In Scenario 5, hybrid Sup35 does not incor-
porate into a polymer.
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Thus, the probability h is a key parameter defining the effi-
ciency of prion elimination. In our experiments, hwas always
low because we never observed complete [PSI] loss. Fur-
thermore, low h implies that, in prion polymers made up of
two different proteins, these proteins are not randomly
mixed but rather are arranged in stretches of similar mole-
cules. Consequently, the levels of co-polymerization of het-
erologous Sup35 are proportional to both the probability h
to initiate such a stretch and the average number of these
molecules in a stretch.
The expression of Sup35-bay and Sup35-mik induced loss of
both the W1 and W2 [PSI] variants with comparable fre-
quency, although the amount of co-polymerized Sup35-mik
was much higher compared with Sup35-bay. This leads us to
suggest that these proteins joined onto Sup35-cer polymers
with comparable frequency, but Sup35-mik formed relatively
long homopolymeric stretches (Fig. 5, Scenario 2), whereas
Sup35-bay joined as a single or a small number of molecules
(Scenarios 3 and 4). The latter also applies to Sup35-par and
Sup35-mik in W3 [PSI] cells.
It may appear paradoxical that Sup35-par eliminated [PSI]
inefficiently despite its efficient co-polymerization with Sup35-
cer in the S, W1, andW2 [PSI] cells. This could be explained,
at least in part, by the observation that the levels of soluble
Sup35-par in the considered cells were significantly lower than
those of any other hybrid Sup35 proteins we examined. The
probability h should be proportional to the levels of soluble
heterologous Sup35; thus, h and, correspondingly, the [PSI]
curing were low in these cases.
Implications for Elimination of Prions and Amyloids—In this
work, we observed that even minor incorporation of heter-
ologous Sup35 could cause a significant loss of native [PSI].
It appears very likely that altered variants of the Sup35 prion-
forming domain can be found that are able to join to the
Sup35-cer polymer with higher frequencies and that would
thus be able to rapidly eliminate the S. cerevisiae [PSI]
prion. Such alleles may be generated via mutagenesis of the
native or heterologous Sup35 prion-forming domains. In a
similar way, altered alleles of the mammalian prion and amy-
loid proteins may be found that would eliminate mammalian
prions or block formation of amyloids. It is important to note
that, although the induced prion curing can rely on two
mechanisms, the conversion to a non-heritable amyloid fold
and interference with polymerization via polymer end cap-
ping, the inhibition of amyloid formation can rely only on the
latter. The inhibition of mammalian prion propagation by a
heterologous protein has already been described in studies
with murine neuroblastoma cells, where hamster PrP and
several of its mutants profoundly interfered with prion prop-
agation by mouse PrP (29).
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